{"id":12056,"date":"2015-02-27T11:13:28","date_gmt":"2015-02-27T10:13:28","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=12056"},"modified":"2015-02-27T11:13:28","modified_gmt":"2015-02-27T10:13:28","slug":"cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/","title":{"rendered":"\u00bfHacia d\u00f3nde va la investigaci\u00f3n en s\u00edndrome coronario agudo e insuficiencia card\u00edaca?"},"content":{"rendered":"<p>Seg\u00fan la Organizaci\u00f3n Mundial de la Salud (OMS), <b>la enfermedad cardiovascular es la causa m\u00e1s importante de muerte en todo el mundo y todav\u00eda est\u00e1 en ascenso.<\/b>\u00a0La intervenci\u00f3n de los profesionales en la prevenci\u00f3n del s\u00edndrome coronario agudo (SCA) y la insuficiencia card\u00edaca (IC), la reducci\u00f3n de los factores de riesgo cardiovascular y la mejora de la adherencia a los tratamientos, ha reducido significativamente la mortalidad cardiovascular. Sin embargo, los datos de estudios recientes muestran que uno de cada seis pacientes con SCA muere durante el primer a\u00f1o despu\u00e9s de haber sufrido un primer episodio.<\/p>\n<p>Para conocer hacia d\u00f3nde va la investigaci\u00f3n en s\u00edndrome coronario agudo e insuficiencia card\u00edaca, saber cu\u00e1les son los nuevos retos cl\u00ednicos y terap\u00e9uticos y profundizar en el conocimiento de los tratamientos farmacol\u00f3gicos desde el manejo inicial hasta la atenci\u00f3n primaria, el Colegio organiz\u00f3 el curso \u201cActualizaci\u00f3n en el s\u00edndrome coronario agudo y la insuficiencia card\u00edaca\u201d para farmac\u00e9uticos de atenci\u00f3n primaria, de hospitales y comunitarios. Ocurri\u00f3 el 12 de febrero.<\/p>\n<p style=\"text-align: center;\"><img fetchpriority=\"high\" decoding=\"async\" class=\"wp-image-12057 aligncenter\" alt=\"curs-sindrome-coronaria (1)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2015\/02\/curs-sindrome-coronaria-1.jpg\" width=\"509\" height=\"243\" \/><\/p>\n<p><a href=\"http:\/\/www.portalfarma.com\/Profesionales\/Notas-de-prensa\/Paginas\/Comunicado-Organizacion-Farmaceutica-Colegial-Distribucion-ilegal-de-medicamentos.aspx\" target=\"_blank\" rel=\"noopener\"><div class=\"box shadow\"><\/a>\u201cUn curso interesante y controvertido desde el punto de vista del debate sobre el rol que debe tener cada nivel asistencial en el seguimiento de este tipo de pacientes y al mismo tiempo muy enriquecedor al contar con la presencia de farmac\u00e9uticos de todos los \u00e1mbitos asistenciales \u201d, explica<b> Roser Vall\u00e8s, vocal de Atenci\u00f3n Primaria del COFB y coordinadora del curso.<\/b><\/div><\/p>\n<p>Esta formaci\u00f3n, que pudo cursarse presencialmente y online con el apoyo Webinar (fue retransmitida en paralelo a la sesi\u00f3n presencial a trav\u00e9s de Internet) fue una reflexi\u00f3n conjunta con diferentes especialistas con puntos de vista diversos sobre la cl\u00ednica y la terap\u00e9utica farmacol\u00f3gica del s\u00edndrome coronario agudo y la insuficiencia card\u00edaca.<\/p>\n\n<p><b>Lina <\/b><b>Badim\u00f3n<\/b>, farmac\u00e9utica y m\u00e9dica especialista y directora del Centro de Investigaci\u00f3n Cardiovascular (CSIC-ICCC), Centro Mixto del Consejo Superior de Investigaciones Cient\u00edficas (CSIC) y el Instituto Catal\u00e1n de Ciencias Cardiovasculares (ICCC) en el Hospital de la Santa Cruz y San Pablo-UAB, y el <b>Antoni Bay\u00e9s<\/b>, presidente de la Sociedad de Cardiolog\u00eda y Director de Servicio de Cardiolog\u00eda del Hospital Germans Trias y Pujol de Badalona, ofrecieron, por un lado, una charla sobre las novedades en las que se est\u00e1 trabajando actualmente en el abordaje farmacol\u00f3gico de la s\u00edndrome coronario agudo y cu\u00e1les son las l\u00edneas de futuro en la b\u00fasqueda de tratamientos que mejoren el pron\u00f3stico de este problema de salud. Por otra parte, el dr. Bay\u00e9s present\u00f3 un<strong> nuevo modelo de organizaci\u00f3n multidisciplinar, coordinado desde el hospital, para mejorar la atenci\u00f3n sanitaria a los pacientes con insuficiencia card\u00edaca, y donde es fundamental la coordinaci\u00f3n y la integraci\u00f3n con la actividad asistencial de la atenci\u00f3n primaria y de la oficina de farmacia<\/strong>. Ambos aportaron nuevas ideas en el manejo de estas dos patolog\u00edas, desde el punto de vista de la investigaci\u00f3n y del \u00e1mbito hospitalario, que ayudaron a que los asistentes se hicieran una idea de cu\u00e1l ser\u00e1 el futuro en el abordaje terap\u00e9utico de estas dos patolog\u00edas.<\/p>\n<figure id=\"attachment_12059\" aria-describedby=\"caption-attachment-12059\" style=\"width: 306px\" class=\"wp-caption alignleft\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2015\/02\/curs-sindrome-coronaria-3.jpg\"><img decoding=\"async\" class=\"wp-image-12059\" alt=\"curs-sindrome-coronaria (3)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2015\/02\/curs-sindrome-coronaria-3.jpg\" width=\"306\" height=\"204\" \/><\/a><figcaption id=\"caption-attachment-12059\" class=\"wp-caption-text\">De izquierda a derecha, Antoni Bay\u00e9s, Roser Vall\u00e8s, Lina Badim\u00f3n, Ana M. de Andr\u00e9s y Natalia L\u00f3pez<\/figcaption><\/figure>\n<p>En la segunda parte del curso, <b>Ana M. de Andr\u00e9s<\/b>, farmac\u00e9utica especialista en farmacia hospitalaria que trabaja en el \u00c1mbito de Evaluaci\u00f3n de Farmacia de la Agencia de Calidad y Evaluaci\u00f3n Sanitarias de Catalu\u00f1a (AQuAS), y <b>Natalia L\u00f3pez<\/b>, m\u00e9dica de familia del EAP Congreso-CS Maragall SAP Derecha \u2013 Barcelona Ciudad, explicaron cu\u00e1les son las recomendaciones actuales en el manejo farmacol\u00f3gico de estas dos patolog\u00edas, s\u00edndrome coronario agudo e insuficiencia card\u00edaca, sobre todo en el \u00e1mbito del atenci\u00f3n primaria. Tambi\u00e9n ayudaron a esclarecer aspectos controvertidos en la selecci\u00f3n de las mejores opciones terap\u00e9uticas actuales teniendo en cuenta la calidad y la seguridad de estas opciones.<\/p>\n<p align=\"right\"><b>Con el patrocinio de:<\/b><\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"http:\/\/www.astrazeneca.es\/inicio\/\" target=\"_blank\" rel=\"noopener\"><\/p>\n<p align=\"right\"><img decoding=\"async\" class=\"size-full wp-image-6822 alignright\" alt=\"astrazeneca_logo\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2014\/06\/astrazeneca_logo.jpg\" width=\"150\" height=\"36\" \/><\/p>\n<p><\/a><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>Seg\u00fan la Organizaci\u00f3n Mundial de la Salud (OMS), la enfermedad cardiovascular es la mayor causa de muerte en todo el mundo y todav\u00eda est\u00e1 en ascenso. La intervenci\u00f3n de los profesionales en la prevenci\u00f3n del s\u00edndrome coronario agudo (SCA) y la insuficiencia card\u00edaca (IC), la reducci\u00f3n de los factores de riesgo cardiovascular y [\u2026]<\/p>","protected":false},"author":1,"featured_media":12057,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[938,70],"class_list":["post-12056","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-atencio-primaria","tag-formacio"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Cap on va la recerca en s\u00edndrome coron\u00e0ria aguda i insufici\u00e8ncia card\u00edaca? - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cap on va la recerca en s\u00edndrome coron\u00e0ria aguda i insufici\u00e8ncia card\u00edaca? - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"Segons l\u2019Organitzaci\u00f3 Mundial de la Salut (OMS), la malaltia cardiovascular \u00e9s la causa m\u00e9s important de mort a tot el m\u00f3n i encara est\u00e0 en ascens.\u00a0La intervenci\u00f3 dels professionals en la prevenci\u00f3 de\u00a0la s\u00edndrome coron\u00e0ria aguda (SCA) i la insufici\u00e8ncia card\u00edaca (IC), la reducci\u00f3 dels factors de risc cardiovascular i [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-02-27T10:13:28+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Cap on va la recerca en s\u00edndrome coron\u00e0ria aguda i insufici\u00e8ncia card\u00edaca?\",\"datePublished\":\"2015-02-27T10:13:28+00:00\",\"dateModified\":\"2015-02-27T10:13:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/\"},\"wordCount\":739,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Atenci\u00f3 prim\u00e0ria\",\"Formaci\u00f3\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/\",\"name\":\"Cap on va la recerca en s\u00edndrome coron\u00e0ria aguda i insufici\u00e8ncia card\u00edaca? - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2015-02-27T10:13:28+00:00\",\"dateModified\":\"2015-02-27T10:13:28+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cap on va la recerca en s\u00edndrome coron\u00e0ria aguda i insufici\u00e8ncia card\u00edaca?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cap on va la recerca en s\u00edndrome coron\u00e0ria aguda i insufici\u00e8ncia card\u00edaca? - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/","og_locale":"es_ES","og_type":"article","og_title":"Cap on va la recerca en s\u00edndrome coron\u00e0ria aguda i insufici\u00e8ncia card\u00edaca? - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"Segons l\u2019Organitzaci\u00f3 Mundial de la Salut (OMS), la malaltia cardiovascular \u00e9s la causa m\u00e9s important de mort a tot el m\u00f3n i encara est\u00e0 en ascens.\u00a0La intervenci\u00f3 dels professionals en la prevenci\u00f3 de\u00a0la s\u00edndrome coron\u00e0ria aguda (SCA) i la insufici\u00e8ncia card\u00edaca (IC), la reducci\u00f3 dels factors de risc cardiovascular i [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2015-02-27T10:13:28+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"wpAdminCofbOrg","Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Cap on va la recerca en s\u00edndrome coron\u00e0ria aguda i insufici\u00e8ncia card\u00edaca?","datePublished":"2015-02-27T10:13:28+00:00","dateModified":"2015-02-27T10:13:28+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/"},"wordCount":739,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/#primaryimage"},"thumbnailUrl":"","keywords":["Atenci\u00f3 prim\u00e0ria","Formaci\u00f3"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/","url":"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/","name":"Cap on va la recerca en s\u00edndrome coron\u00e0ria aguda i insufici\u00e8ncia card\u00edaca? - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/#primaryimage"},"thumbnailUrl":"","datePublished":"2015-02-27T10:13:28+00:00","dateModified":"2015-02-27T10:13:28+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2015\/02\/27\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Cap on va la recerca en s\u00edndrome coron\u00e0ria aguda i insufici\u00e8ncia card\u00edaca?"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"Segons l\u2019Organitzaci\u00f3 Mundial de la Salut (OMS), la malaltia cardiovascular \u00e9s la causa m\u00e9s important de mort a tot el m\u00f3n i encara est\u00e0 en ascens.\u00a0La intervenci\u00f3 dels professionals en la prevenci\u00f3 de\u00a0la s\u00edndrome coron\u00e0ria aguda (SCA) i la insufici\u00e8ncia card\u00edaca (IC), la reducci\u00f3 dels factors de risc cardiovascular i [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/12056","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=12056"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/12056\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=12056"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=12056"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=12056"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}